About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 USD | +12.17% | -9.09% | -76.23% |
May. 13 | Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index | CI |
May. 09 | Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M | MT |
About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-76.23% | 1.43M | |
+13.71% | 130B | |
-8.50% | 10.97B | |
-3.55% | 8.42B | |
+39.26% | 5.57B | |
-24.12% | 4.59B | |
+7.80% | 3.42B | |
-11.14% | 2.73B | |
-11.32% | 2.08B | |
-13.47% | 1.92B |